Nick B. Tressler
Chief Financial Officer · Vistagen Therapeutics, Inc.
Individual
- 2025
- Jul 2, 2026
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Nick B. Tressler's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nick B. Tressler?
Nick B. Tressler is a corporate insider, tracked as Chief Financial Officer of Vistagen Therapeutics, Inc. (VTGN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Nick B. Tressler last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 3 filings going back to 2025.
